Skip to main navigation Skip to search Skip to main content

A single-shot vaccine approach for the universal influenza A vaccine candidate M2e

Research output: Contribution to journal › Article › Research › peer-review

Abstract

SignificanceAlthough the need for a universal influenza vaccine has long been recognized, only a handful of candidates have been identified so far, with even fewer advancing in the clinical pipeline. The 24-amino acid ectodomain of M2 protein (M2e) has been developed over the past two decades. However, M2e-based vaccine candidates have shortcomings, including the need for several administrations and the lack of sustained antibody titers over time. We report here a vaccine targeting strategy that has the potential to confer sustained and strong protection upon a single shot of a small amount of M2e antigen. The current COVID-19 pandemic has highlighted the importance of developing versatile, powerful platforms for the rapid deployment of vaccines against any incoming threat.

Original languageEnglish
Article numbere2025607119
Number of pages10
JournalProceedings of the National Academy of Sciences of the United States of America
Volume119
Issue number13
DOIs
Publication statusPublished - 29 Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clec9A
  • M2e
  • single shot
  • universal influenza A vaccine

Cite this